OOIR: Observatory of International Research

Papers

(The H4-Index of European Journal of Preventive Cardiology is 35. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)

Article	Citations
Burden of heart failure and underlying causes in 195 countries and territories from 1990 to 2017	324
2021 ESC Guidelines on cardiovascular disease prevention in clinical practice	253
Exercise intensity assessment and prescription in cardiovascular rehabilitation and beyond: why and how: a position statement from the Secondary Prevention and Rehabilitation Section of the European A	135
Obesity and cardiovascular disease: mechanistic insights and management strategies. A joint position paper by the World Heart Federation and World Obesity Federation	110
Frailty in cardiology: definition, assessment and clinical implications for general cardiology. A consensus document of the Council for Cardiology Practice (CCP), Association for Acute Cardio Vascular	97
Burden of ischemic heart disease and its attributable risk factors in 204 countries and territories, 1990–2019	94
Effectiveness of home-based cardiac telerehabilitation as an alternative to Phase 2 cardiac rehabilitation of coronary heart disease: a systematic review and meta-analysis	93
Excess deaths in people with cardiovascular diseases during the COVID-19 pandemic	92
Personalized exercise prescription in the prevention and treatment of arterial hypertension: a Consensus Document from the European Association of Preventive Cardiology (EAPC) and the ESC Council on H	88
Impact of sarcopenia on prognosis in patients with heart failure with reduced and preserved ejection fraction	78
Improved oral hygiene care is associated with decreased risk of occurrence for atrial fibrillation and heart failure: A nationwide population-based cohort study	72
Statin use and risk of dementia or Alzheimer’s disease: a systematic review and meta-analysis of observational studies	70
Global trends and regional differences in incidence and mortality of cardiovascular disease, 1990−2019: findings from 2019 global burden of disease study	69
Risk of cardiovascular events in patients with non-alcoholic fatty liver disease: a systematic review and meta-analysis	67
Keys to early diagnosis of cardiac amyloidosis: red flags from clinical, laboratory and imaging findings	61
Role of gender, age and BMI in prognosis of heart failure	60
Statin therapy and lipoprotein(a) levels: a systematic review and meta-analysis	59
Life’s Essential 8 and the risk of cardiovascular disease death and all-cause mortality in Finnish men	55
Second consensus document on diagnosis and management of acute deep vein thrombosis: updated document elaborated by the ESC Working Group on aorta and peripheral vascular diseases and the ESC Working	53
Predicting the transition to and progression of heart failure with preserved ejection fraction: a weighted risk score using bio-humoural, cardiopulmonary, and echocardiographic stress testing	51
Poor adherence to lifestyle recommendations in patients with coronary heart disease: results from the EUROASPIRE surveys	49
Effect of sodium-glucose cotransporter-2 inhibitors on cardiac remodelling: a systematic review and meta-analysis	48
Effects of exercise rehabilitation in patients with long coronavirus disease 2019	46
How to optimize the adherence to a guideline-directed medical therapy in the secondary prevention of cardiovascular diseases: a clinical consensus statement from the European Association of Preventive	45
Utility of the CHA2DS2-VASc score for predicting ischaemic stroke in patients with or without atrial fibrillation: a systematic review and meta-analysis	44

Paediatric familial hypercholesterolaemia screening in Europe: public policy background and recommendations	42
‘Life’s Essential 8’ cardiovascular health with premature cardiovascular disease and all-cause mortality in young adults: the Kailuan prospective cohort study	41
Tea consumption and the risk of atherosclerotic cardiovascular disease and all-cause mortality: The China-PAR project	40
Role of comorbidities in heart failure prognosis Part I: Anaemia, iron deficiency, diabetes, atrial fibrillation	40
The association between daily step count and all-cause and cardiovascular mortality: a meta-analysis	40
Gut microbiome and risk of ischaemic stroke: a comprehensive Mendelian randomization study	38
Vascular ageing: moving from bench towards bedside	38
Triglyceride–glucose index in the development of heart failure and left ventricular dysfunction: analysis of the ARIC study	37
Cardiovascular effects of doping substances, commonly prescribed medications and ergogenic aids in relation to sports: a position statement of the sport cardiology and exercise nucleus of the European	36
External validation of the HCM Risk-Kids model for predicting sudden cardiac death in childhood hypertrophic cardiomyopathy	35
Role of comorbidities in heart failure prognosis Part 2: Chronic kidney disease, elevated serum uric acid	35